Načítá se...

Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss

BACKGROUND AND OBJECTIVE: An increasing body of evidence suggests that the use of probiotic bacteria is a promising intervention approach for the treatment of inflammatory diseases with polymicrobial etiology. The objective of this study was to determine whether Lactobacillus brevis CD2 could inhibi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Maekawa, Tomoki, Hajishengallis, George
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119090/
https://ncbi.nlm.nih.gov/pubmed/24483135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jre.12164
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!